Neurogene (NGNE) Short Interest Ratio & Short Volume

Neurogene logo
$23.10 -0.20 (-0.86%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$22.88 -0.22 (-0.95%)
As of 07:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neurogene Short Interest Overview

As of October 30, 2026, Neurogene (NGNE) had a short interest of 5.69 million shares sold short, representing 32.17% of the public float. This marks an 11.63% increase in short interest since the prior report. The short interest ratio (days to cover) is 17.0, meaning it would take 17.0 days of the average trading volume of 294,110 shares to cover all short positions.

Current Short Interest
5,685,998 shares
Previous Short Interest
5,093,623 shares
Change Vs. Previous Report
11.63%
Dollar Volume Sold Short
$156.65 million
Short Interest Ratio
17.0 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
20,700,000 shares
Short Percent of Float
32.17%
Today's Trading Volume
278,143 shares
Average Trading Volume
294,110 shares
Today's Volume Vs. Average
95%
Short Selling Neurogene?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Neurogene and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

NGNE Short Interest Over Time

NGNE Days to Cover Over Time

NGNE Percentage of Float Shorted Over Time

Neurogene Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20265,685,998 shares $156.65 million +11.6%32.2%16.95 $27.55
10/15/20265,093,623 shares $121.99 million +2.4%28.8%14.36 $23.95
9/30/20264,974,749 shares $138.40 million +51.7%28.1%11.73 $27.82
9/15/20263,280,172 shares $110.51 million +4.6%18.6%16.85 $33.69
8/31/20263,135,369 shares $113.63 million +3.2%17.7%13.58 $36.24
8/14/20263,038,441 shares $109.81 million +1.1%17.2%16.81 $36.14
7/31/20263,005,232 shares $98.84 million +2.6%21.5%16.15 $32.89
7/15/20262,928,178 shares $115.52 million -12.7%21.0%7.57 $39.45
6/30/20263,352,320 shares $105.43 million -5.5%24.0%13.48 $31.45
6/15/20263,548,175 shares $105.95 million +0.1%25.4%22.94 $29.86
5/29/20263,545,963 shares $100.49 million -1.6%25.4%27.48 $28.34
5/15/20263,603,655 shares $107.46 million -3.1%25.8%24.65 $29.82
4/30/20263,720,441 shares $97.07 million -7.3%26.4%19.85 $26.09
4/15/20264,011,809 shares $96.28 million -0.4%28.7%28.64 $24.00
3/31/20264,029,257 shares $81.23 million +3.7%28.9%25.19 $20.16
3/13/20263,885,559 shares $83.58 million +5.8%27.8%19.91 $21.51
2/27/20263,673,771 shares $86.30 million +1.9%26.3%15.61 $23.49
2/13/20263,605,074 shares $62.66 million +0.4%25.8%32.65 $17.38
1/30/20263,591,099 shares $63.42 million +1.6%25.7%31.88 $17.66
1/15/20263,536,210 shares $63.86 million +1.0%25.3%20.17 $18.06
12/31/20253,502,155 shares $72.14 million -1.0%25.1%18.12 $20.60
12/15/20253,538,773 shares $71.70 million +7.7%25.4%18.3 $20.26
11/28/20253,285,408 shares $66.56 million -0.9%23.5%15.75 $20.26
11/14/20253,315,140 shares $75.49 million +16.6%26.3%11 $22.77
10/31/20252,844,441 shares $97.45 million -0.5%22.6%13.06 $34.26
10/15/20252,860,000 shares $98.30 million +0.7%23.6%17.3 $34.37
9/30/20252,840,000 shares $49.22 million +0.7%23.6%18 $17.33
9/15/20252,820,000 shares $49.21 million +2.9%23.4%17.5 $17.45
8/31/20252,740,000 shares $50.64 million +3.0%22.7%18.2 $18.48
8/15/20252,660,000 shares $54.56 million +2.7%22.1%15.6 $20.51
7/31/20252,590,000 shares $56.38 million +1.6%22.0%13.8 $21.77
7/15/20252,550,000 shares $54.75 million +15.4%21.7%11.8 $21.47
6/30/20252,210,000 shares $33.04 million -1.8%18.8%8.5 $14.95
6/15/20252,250,000 shares $44.46 million -5.9%19.2%8.6 $19.76
5/31/20252,390,000 shares $41.13 million -11.5%20.3%8.7 $17.21
5/15/20252,700,000 shares $52.30 million -8.5%23.0%10.1 $19.37
4/30/20252,950,000 shares $44.25 million +3.2%25.1%10.8 $15.00
4/15/20252,860,000 shares $32.49 million +17.2%24.4%10.2 $11.36
3/31/20252,440,000 shares $28.57 million +11.9%19.9%9.2 $11.71
3/15/20252,180,000 shares $36.41 million +11.2%12.6%9.3 $16.70
The Democrats can’t stop this (Ad)

Porter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypassing Congress under a national emergency. His new briefing outlines three steps to prepare and names a core group of assets tied to the initiative that he says could surge. He points to the 1970s Nixon-era reset, which reportedly minted an average of 1,300 new millionaires a day for over half a century.tc pixel

Get Porter Stansberry's briefing on Trump's new dollar and the three steps he outlines.
2/28/20251,960,000 shares $34.67 million +12.0%11.3%8 $17.69
2/15/20251,750,000 shares $32.24 million -12.9%10.1%5.4 $18.42
1/31/20252,010,000 shares $31.86 million +10.4%11.4%4.8 $15.85
1/15/20251,820,000 shares $33.74 million No Change10.4%4.6 $18.54
12/31/20241,820,000 shares $41.61 million +13.8%11.3%4.8 $22.86
12/15/20241,600,000 shares $37.62 million +36.8%9.9%4.3 $23.51
11/30/20241,170,000 shares $29.75 million -28.7%10.2%3.4 $25.43
11/15/20241,640,000 shares $56.60 million +79.4%14.2%5.4 $34.52
10/31/2024914,200 shares $40.23 million -2.2%8.9%6.8 $44.01
10/15/2024934,600 shares $46.70 million -50.8%9.1%8.2 $49.97
9/30/20241,900,000 shares $79.72 million +6.2%18.5%16.8 $41.96
9/15/20241,790,000 shares $75.09 million -1.7%17.4%13.7 $41.95
8/31/20241,820,000 shares $68.10 million +4.6%17.7%14.1 $37.42
8/15/20241,740,000 shares $61.98 million +11.5%16.9%13.6 $35.62
7/31/20241,560,000 shares $64.18 million +8.3%13.4%12.6 $41.14
7/15/20241,440,000 shares $66.17 million +34.6%12.4%12.4 $45.95
6/30/20241,070,000 shares $38.94 million +0.9%9.2%9.5 $36.39
6/15/20241,060,000 shares $45.15 million +8.5%9.1%10.1 $42.59
5/31/2024977,400 shares $36.75 million -2.0%8.4%7.8 $37.60
5/15/2024997,800 shares $33.52 million -2.2%8.6%7.5 $33.59
4/30/20241,020,000 shares $35.17 million +3.2%8.9%7.7 $34.48
4/15/2024988,100 shares $36.98 million +9.1%8.6%7.1 $37.43
3/31/2024906,000 shares $46.12 million +130.4%7.9%6.7 $50.90
3/15/2024393,200 shares $14.76 million +50.8%3.4%3.4 $37.53
2/29/2024260,700 shares $8.10 million +68.2%2.3%3.4 $31.07
2/15/2024155,000 shares $4.65 million +295.4%1.3%2.4 $30.00
1/31/202439,200 shares $1.18 million No Change0.4%0.8 $30.16

NGNE Short Interest - Frequently Asked Questions

Short interest is the volume of Neurogene shares that have been sold short but have not yet been covered or closed out. As of October 30th, investors have sold 5,685,998 shares of NGNE short. 32.17% of Neurogene's shares are currently sold short. Learn More on Neurogene's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGNE shares currently have a short interest ratio of 17.0. Learn More on Neurogene's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 32.17% of Neurogene's floating shares are currently sold short.

Neurogene saw an increase in short interest since the prior report. As of October 30th, there was short interest totaling 5,685,998 shares, an increase of 11.6% from the previous total of 5,093,623 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

32.17% of Neurogene's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Neurogene: Maze Therapeutics, Inc. (12.71%), Veracyte, Inc. (12.08%), BioCryst Pharmaceuticals, Inc. (11.17%), Hemab Therapeutics Holdings, Inc. (7.08%), Recursion Pharmaceuticals, Inc. (24.47%), Zenas BioPharma, Inc. (22.33%), Agios Pharmaceuticals, Inc. (11.55%), Kailera Therapeutics, Inc. (6.30%), Mesoblast Limited (3.39%), Stoke Therapeutics, Inc. (18.13%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling NGNE is an investing strategy that aims to generate trading profit from Neurogene as its price is falling. NGNE shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Neurogene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGNE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGNE, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NGNE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:NGNE is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners